Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 3
2007 3
2008 4
2010 1
2011 1
2012 6
2013 6
2014 4
2015 3
2016 7
2017 5
2018 4
2019 2
2020 3
2021 5
2022 3
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma.
Yonezawa H, Narita Y, Nagane M, Mishima K, Terui Y, Arakawa Y, Asai K, Fukuhara N, Sugiyama K, Shinojima N, Aoi A, Nishikawa R. Yonezawa H, et al. Among authors: mishima k. Neurooncol Adv. 2024 Apr 22;6(1):vdae037. doi: 10.1093/noajnl/vdae037. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38690230 Free PMC article.
Rapidly Progressing Intramedullary Spinal Cord Abscess: A Case Report.
Ehara T, Suzuki T, Mizuno R, Shirahata M, Mishima K, Homma T. Ehara T, et al. Among authors: mishima k. NMC Case Rep J. 2024 Feb 14;11:43-47. doi: 10.2176/jns-nmc.2023-0144. eCollection 2024. NMC Case Rep J. 2024. PMID: 38454915 Free PMC article.
Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
On J, Natsumeda M, Takahashi H, Koyama A, Shibuma S, Shibata N, Watanabe J, Saito S, Kanemaru Y, Tsukamoto Y, Okada M, Ogura R, Eda T, Tada M, Shimizu H, Adachi JI, Mishima K, Nishikawa R, Kakita A, Oishi M. On J, et al. Among authors: mishima k. J Neurooncol. 2024 Jan;166(2):273-282. doi: 10.1007/s11060-023-04555-5. Epub 2024 Jan 16. J Neurooncol. 2024. PMID: 38227143
Karnofsky Performance Status and quality of life in patients with relapsed or refractory primary CNS lymphoma from a phase I/II study of tirabrutinib.
Arakawa Y, Narita Y, Nagane M, Mishima K, Terui Y, Yonezawa H, Asai K, Fukuhara N, Sugiyama K, Shinojima N, Aoi A, Nishikawa R. Arakawa Y, et al. Among authors: mishima k. Neurooncol Adv. 2023 Sep 14;5(1):vdad109. doi: 10.1093/noajnl/vdad109. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37744697 Free PMC article.
Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C.
Mishima K, Nishikawa R, Narita Y, Mizusawa J, Sumi M, Koga T, Sasaki N, Kinoshita M, Nagane M, Arakawa Y, Yoshimoto K, Shibahara I, Shinojima N, Asano K, Tsurubuchi T, Sasaki H, Asai A, Sasayama T, Momii Y, Sasaki A, Nakamura S, Kojima M, Tamaru JI, Tsuchiya K, Gomyo M, Abe K, Natsumeda M, Yamasaki F, Katayama H, Fukuda H. Mishima K, et al. Neuro Oncol. 2023 Apr 6;25(4):687-698. doi: 10.1093/neuonc/noac246. Neuro Oncol. 2023. PMID: 36334050 Free PMC article. Clinical Trial.
66 results